DDIEM: drug database for inborn errors of metabolism
Abstract Background Inborn errors of metabolism (IEM) represent a subclass of rare inherited diseases caused by a wide range of defects in metabolic enzymes or their regulation. Of over a thousand characterized IEMs, only about half are understood at the molecular level, and overall the development...
Main Authors: | Marwa Abdelhakim, Eunice McMurray, Ali Raza Syed, Senay Kafkas, Allan Anthony Kamau, Paul N Schofield, Robert Hoehndorf |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-06-01
|
Series: | Orphanet Journal of Rare Diseases |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13023-020-01428-2 |
Similar Items
-
Combining lexical and context features for automatic ontology extension
by: Sara Althubaiti, et al.
Published: (2020-01-01) -
Inborn Errors of Immunity and Cancer
by: Alessandra Tiri, et al.
Published: (2021-04-01) -
Drug Repositioning: New Approaches and Future Prospects for Life-Debilitating Diseases and the COVID-19 Pandemic Outbreak
by: Zheng Yao Low, et al.
Published: (2020-09-01) -
Systematic Review: Drug Repositioning for Congenital Disorders of Glycosylation (CDG)
by: Sandra Brasil, et al.
Published: (2022-08-01) -
Epigenetic Alterations in Inborn Errors of Immunity
by: Roberta Romano, et al.
Published: (2022-02-01)